„First Line“
Suchergebnisse
3.416 Treffer
-
Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer
-
Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya
-
Nivolumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: a cost-effectiveness analysis
-
Biologically Active Linear Metabolites of Arachidonic Acid—The First Endogenous Ligand of the Cannabinoid Receptor
-
Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment for mismatch-repair-deficient (dMMR) or microsatellite-instability-high (MSI-H) advanced or metastatic colorectal cancer from the perspective of the Chinese health-care system
-
First-line nivolumab plus ipilimumab for unresectable MPM in China: a cost-effectiveness analysis
-
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial
-
Geriatric nutritional risk index as a prognostic marker of first-line immune checkpoint inhibitor combination therapy in patients with renal cell carcinoma: a retrospective multi-center study
-
Prognostic Effect of Performance Status on Outcomes of Patients with Colorectal Cancer Receiving First-Line Chemotherapy: A Meta-analysis
-
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma
-
Cost-Effectiveness Analysis of Atezolizumab versus Platinum-Based Chemotherapy as First-Line Treatment for Patients with Unresectable Advanced Non-small Cell Lung Cancer with PD-L1 Expression Status in Japan
-
First‐Row Transition‐Metal Complexes with Tetra‐Amido Macrocyclic Ligands for Water and C (sp 3)−H Bond Oxidation: Performance Benchmarking Using Free Energy Relationships
-
Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT
-
PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Study
-
Linear Beam-Down Solar Field Demonstrator: First Results and Validation
-
A phase II trial of paclitaxel (Taxol®) as first line treatment in advanced breast cancer
-
First-order and second-order ε-directional derivatives of a marginal function in convex programming with linear inequality constraints
-
The behaviour of induced discontinuities behind a first order discontinuity wave for a quasi-linear hyperbolic system
-
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC?
-
Optimal control of systems governed by time-delayed, second-order, linear, parabolic partial differential equations with a first boundary condition